OP013/#417 Cost-effectiveness of dostarlimab in advanced recurrent deficient mismatch repair endometrial cancer patients

Dioun, S., Chen, L., Gockley, A., Melamed, A., St Clair, C., Tergas, A., Hou, J., Collado, F., & Wright, J. (2021). OP013/#417 Cost-effectiveness of dostarlimab in advanced recurrent deficient mismatch repair endometrial cancer patients. Oral Featured Posters, A16.1-A16. https://doi.org/10.1136/ijgc-2021-igcs.30
Authors:
Shayan Dioun
L Chen
A.A. Gockley
Alexander Melamed
Caryn St. Clair
Ana I. Tergas
June Y. Hou
F. Khoury Collado
Jason D. Wright
Affiliated Authors:
Shayan Dioun
L Chen
A.A. Gockley
Alexander Melamed
Caryn St. Clair
Ana I. Tergas
June Y. Hou
F. Khoury Collado
Jason D. Wright
Columbia Affiliation:
Subjects:
Molecular Characterization of Colorectal Cancer (OpenAlex Topic)
Gynecologic Oncology (OpenAlex Topic)
elink
Publication Type:
Article
Unique ID:
10.1136/ijgc-2021-igcs.30
DOI:
10.1136/ijgc-2021-igcs.30
Journal:
International Journal of Gynecological Cancer
Publication Date:
Data Source:
OpenAlex
Source Link:
View OpenAlex Record

Record Created: